{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T17:35:22Z","timestamp":1770744922181,"version":"3.49.0"},"reference-count":41,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T00:00:00Z","timestamp":1770076800000},"content-version":"vor","delay-in-days":2712,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2018,8,5]],"date-time":"2018-08-05T00:00:00Z","timestamp":1533427200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Advances in Veterinary Research","award":["#AVR-15-05"],"award-info":[{"award-number":["#AVR-15-05"]}]},{"name":"The Department of Clinical Sciences of Companion Animals, Utrecht University, The Netherlands"},{"name":"Advances in Veterinary Research (AVR)","award":["#AVR-15-05"],"award-info":[{"award-number":["#AVR-15-05"]}]},{"name":"The Department of Clinical Sciences of Companion Animals, Utrecht University, The Netherlands"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2018,9,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The inward rectifier inhibitor pentamidine analogue 6 (PA-6) is effective in cardioversion of goats with persistent rapid pacing induced atrial fibrillation (AF) and is not proarrhythmic in dogs with experimental chronic 3rd-degree AV block. Efficacy and safety in the clinical setting are unknown.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Hypothesis<\/jats:title>\n                    <jats:p>That PA-6 would be effective in converting AF to sinus rhythm (SR) in dogs with naturally occurring AF, without the presence of overt adverse effects.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Animals<\/jats:title>\n                    <jats:p>Ten client-owned large and giant breed dogs.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Animals with persistent or permanent AF were recruited for our prospective study. PA-6 was administered IV as a bolus of 2.5 mg\/kg 10 min\u22121 followed by a maintenance infusion of 0.04 mg\/kg min\u22121 for a maximum of 50 minutes in conscious dogs. Standard 6 lead limb ECG was recorded during the infusion. Visible and audible signs of adverse effects were scored during the entire procedure.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>PA-6 did not induce changes in QRS duration (54.7\u2009\u00b1\u20094.6 versus 56.7\u2009\u00b1\u20096.1 ms, P\u2009=\u2009.42), QTc interval (241.1\u2009\u00b1\u200919.5 versus 258.7\u2009\u00b1\u200919.8 ms, P\u2009=\u2009.061) or RR interval (363.4\u2009\u00b1\u200984.6 versus 440.8\u2009\u00b1\u200996.3 ms, P\u2009=\u2009.072) at the end of the bolus. No cardioversion to SR was observed in any dog. Three dogs displayed no adverse effects. Five dogs had premature ventricular depolarizations during PA-6 infusion on the ECG. Respiratory distress with laryngeal stridor, subtle muscle twitching, and mild generalized muscular weakness were noncardiac adverse effects observed in 5 dogs. Adverse effects resolved spontaneously.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions and Clinical importance<\/jats:title>\n                    <jats:p>Chronic naturally occurring AF in large and giant breed dogs could not be cardioverted to SR by PA-6.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/jvim.15242","type":"journal-article","created":{"date-parts":[[2018,8,7]],"date-time":"2018-08-07T03:43:09Z","timestamp":1533613389000},"page":"1549-1554","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Efficacy of pentamidine analogue 6 in dogs with chronic atrial fibrillation"],"prefix":"10.1093","volume":"32","author":[{"given":"Viktor","family":"Szatm\u00e1ri","sequence":"first","affiliation":[{"name":"Utrecht University Department of Clinical Sciences of Companion Animals, , Utrecht,","place":["The Netherlands"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuan","family":"Ji","sequence":"additional","affiliation":[{"name":"University Medical Center Utrecht Department of Medical Physiology, , Utrecht,","place":["The Netherlands"]},{"name":"Division of Heart and Lungs, University Medical Center Utrecht , Utrecht,","place":["The Netherlands"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bianca van","family":"Herwijnen","sequence":"additional","affiliation":[{"name":"University Medical Center Utrecht Department of Medical Physiology, , Utrecht,","place":["The Netherlands"]},{"name":"Division of Heart and Lungs, University Medical Center Utrecht , Utrecht,","place":["The Netherlands"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mei","family":"Feng","sequence":"additional","affiliation":[{"name":"School of Pharmacy, The University of Kansas Department of Pharmaceutical Chemistry, , Lawrence, Kansas"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael Zhou","family":"Wang","sequence":"additional","affiliation":[{"name":"School of Pharmacy, The University of Kansas Department of Pharmaceutical Chemistry, , Lawrence, Kansas"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandre","family":"Bossu","sequence":"additional","affiliation":[{"name":"University Medical Center Utrecht Department of Medical Physiology, , Utrecht,","place":["The Netherlands"]},{"name":"Division of Heart and Lungs, University Medical Center Utrecht , Utrecht,","place":["The Netherlands"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4225-7942","authenticated-orcid":false,"given":"Marcel A. G.","family":"van der Heyden","sequence":"additional","affiliation":[{"name":"University Medical Center Utrecht Department of Medical Physiology, , Utrecht,","place":["The Netherlands"]},{"name":"Division of Heart and Lungs, University Medical Center Utrecht , Utrecht,","place":["The Netherlands"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2018,9,1]]},"reference":[{"key":"2026020922045727200_jvim15242-bib-0001","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1136\/vr.129.21.470","article-title":"An electrocardiographic survey of cardiac rhythm in Irish wolfhounds","volume":"129","author":"Brownlie","year":"1991","journal-title":"Vet Rec."},{"key":"2026020922045727200_jvim15242-bib-0002","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1053\/tvjl.2000.0506","article-title":"Influence of left atrial enlargement and body weight on the development of atrial fibrillation: retrospective study on 205 dogs","volume":"160","author":"Guglielmini","year":"2000","journal-title":"Vet J."},{"key":"2026020922045727200_jvim15242-bib-0003","first-page":"75","article-title":"Atrial fibrillation in dogs with and without structural or functional cardiac disease: a retrospective study of 109 cases","volume":"7","author":"Menaut","year":"2005","journal-title":"JVet Cardiol."},{"key":"2026020922045727200_jvim15242-bib-0004","first-page":"E1","article-title":"Canine atrial fibrillation","volume":"31","author":"Saunders","year":"2009","journal-title":"Compend Contin Educ Vet."},{"key":"2026020922045727200_jvim15242-bib-0005","first-page":"151","article-title":"Epidemiology of atrial fibrillation in the dog","volume":"6","author":"Westling","year":"2008","journal-title":"Intern J Appl Res Vet Med."},{"key":"2026020922045727200_jvim15242-bib-0006","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1016\/j.cvsm.2004.05.001","article-title":"Management of atrial fibrillation","volume":"34","author":"Gelzer","year":"2004","journal-title":"Vet Clin North Am Small Anim Pract."},{"key":"2026020922045727200_jvim15242-bib-0007","first-page":"85","article-title":"A retrospective evaluation of transthoracic biphasic electrical cardioversion for atrial fibrillation in dogs","volume":"7","author":"Bright","year":"2005","journal-title":"JVet Cardiol."},{"key":"2026020922045727200_jvim15242-bib-0008","first-page":"1224","article-title":"Acute conversion of atrial fibrillation in two dogs by intravenous amiodarone administration","volume":"20","author":"Oyama","year":"2006","journal-title":"JVet Intern Med."},{"key":"2026020922045727200_jvim15242-bib-0009","first-page":"499","article-title":"Combination therapy with digoxin and diltiazem controls ventricular rate in chronic atrial fibrillation in dogs better than digoxin or diltiazem monotherapy: a randomized crossover study in 18 dogs","volume":"23","author":"Gelzer","year":"2009","journal-title":"JVet Intern Med."},{"key":"2026020922045727200_jvim15242-bib-0010","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1161\/CIRCULATIONAHA.111.019927","article-title":"Antiarrhythmic drug therapy for atrial fibrillation","volume":"125","author":"Zimetbaum","year":"2012","journal-title":"Circulation."},{"key":"2026020922045727200_jvim15242-bib-0011","first-page":"921","article-title":"Oral amiodarone therapy in dogs with atrial fibrillation","volume":"20","author":"Saunders","year":"2006","journal-title":"JVet Intern Med."},{"key":"2026020922045727200_jvim15242-bib-0012","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1152\/physrev.00021.2009","article-title":"Inwardly rectifying potassium channels: their structure, function, and physiological roles","volume":"90","author":"Hibino","year":"2010","journal-title":"Physiol Rev."},{"key":"2026020922045727200_jvim15242-bib-0013","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/j.hrthm.2011.01.038","article-title":"Toward specific cardiac I(K1) modulators for in vivo application: old drugs point the way","volume":"8","author":"Van der Heyden","year":"2011","journal-title":"Heart Rhythm."},{"key":"2026020922045727200_jvim15242-bib-0014","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1093\/cvr\/cvt103","article-title":"Efficient and specific cardiac IK1 inhibition by a new pentamidine analogue","volume":"99","author":"Takanari","year":"2013","journal-title":"Cardiovasc Res."},{"key":"2026020922045727200_jvim15242-bib-0015","doi-asserted-by":"crossref","first-page":"2576","DOI":"10.1111\/bph.13869","article-title":"The inward rectifier current inhibitor PA-6 terminates atrial fibrillation and does not cause ventricular arrhythmias in dedicated goat and dog models","volume":"174","author":"Ji","year":"2017","journal-title":"Br J Pharmacol."},{"key":"2026020922045727200_jvim15242-bib-0016","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.pharmthera.2008.03.006","article-title":"The canine model with chronic, complete atrio-ventricular block","volume":"119","author":"Oros","year":"2008","journal-title":"Pharmacol Ther."},{"key":"2026020922045727200_jvim15242-bib-0017","first-page":"390","article-title":"Textbook of Veterinary Internal Medicine: Diseases of the Dog and the Cat","author":"Anderson","year":"2017","edition":"8"},{"key":"2026020922045727200_jvim15242-bib-0018","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/0160-5402(89)90015-6","article-title":"An improved method to correct the QT interval of the electrocardiogram for changes in heart rate","volume":"22","author":"Van de Water","year":"1989","journal-title":"JPharmacol Methods."},{"key":"2026020922045727200_jvim15242-bib-0019","doi-asserted-by":"crossref","first-page":"H725","DOI":"10.1152\/ajpheart.00440.2013","article-title":"Chronic atrial fibrillation causes left ventricular dysfunction in dogs but not goats: experience with dogs, goats, and pigs","volume":"305","author":"Dosdall","year":"2013","journal-title":"Am J Physiol Heart Circ Physiol."},{"key":"2026020922045727200_jvim15242-bib-0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4247\/AM.2015.ABE100","article-title":"A Little Too Much: Cardiac Electrophysiological Effects of Elevated Inward Rectifying Current Carried by the KIR2.1 Ion Channel Protein","volume":"7","author":"Veldhuis","year":"2015","journal-title":"Adaptive Med."},{"key":"2026020922045727200_jvim15242-bib-0021","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1172\/JCI62185","article-title":"MicroRNA-26 governs profibrillatory inward-rectifier potassium current changes in atrial fibrillation","volume":"123","author":"Luo","year":"2013","journal-title":"JClin Invest."},{"key":"2026020922045727200_jvim15242-bib-0022","doi-asserted-by":"crossref","first-page":"3697","DOI":"10.1161\/CIRCULATIONAHA.105.575332","article-title":"The G protein-gated potassium current I(K,ACh) is constitutively active in patients with chronic atrial fibrillation","volume":"112","author":"Dobrev","year":"2005","journal-title":"Circulation."},{"key":"2026020922045727200_jvim15242-bib-0023","doi-asserted-by":"crossref","first-page":"757","DOI":"10.2165\/00003495-200969070-00001","article-title":"Novel approaches for pharmacological management of atrial fibrillation","volume":"69","author":"Ehrlich","year":"2009","journal-title":"Drugs."},{"key":"2026020922045727200_jvim15242-bib-0024","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1093\/europace\/euu192","article-title":"Is the acetylcholine-regulated inwardly rectifying potassium current a viable antiarrhythmic target? Translational discrepancies of AZD2927 and A7071 in dogs and humans","volume":"17","author":"Walfridsson","year":"2015","journal-title":"Europace."},{"key":"2026020922045727200_jvim15242-bib-0025","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1016\/S0026-895X(25)09610-5","article-title":"Effects of Volatile Anesthetics on the G Protein-Regulated Muscarinic Potassium Channel","volume":"50","author":"Magyar","year":"1996","journal-title":"Mol Pharmacol."},{"key":"2026020922045727200_jvim15242-bib-0026","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1097\/00000542-200107000-00025","article-title":"Differential effects of general anesthetics on G protein-coupled inwardly rectifying and other potassium channels","volume":"95","author":"Yamakura","year":"2001","journal-title":"Anesthesiology."},{"key":"2026020922045727200_jvim15242-bib-0027","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1161\/01.CIR.100.1.87","article-title":"Promotion of atrial fibrillation by heart failure in dogs: atrial remodeling of a different sort","volume":"100","author":"Li","year":"1999","journal-title":"Circulation."},{"key":"2026020922045727200_jvim15242-bib-0028","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1161\/01.CIR.102.12.1454","article-title":"Electrical, morphological, and ultrastructural remodeling and reverse remodeling in a canine model of chronic atrial fibrillation","volume":"102","author":"Everett","year":"2000","journal-title":"Circulation."},{"key":"2026020922045727200_jvim15242-bib-0029","first-page":"114","article-title":"Chronicity of atrial fibrillation affects duration of sinus rhythm after transthoracic cardioversion of dogs with naturally occurring atrial fibrillation","volume":"22","author":"Bright","year":"2008","journal-title":"JVet Intern Med."},{"key":"2026020922045727200_jvim15242-bib-0030","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1161\/CIRCEP.109.931634","article-title":"Fibrillatory conduction in the atrial free walls of goats in persistent and permanent atrial fibrillation","volume":"3","author":"Verheule","year":"2010","journal-title":"Circ Arrhythm Electrophysiol."},{"key":"2026020922045727200_jvim15242-bib-0031","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1111\/j.1540-8167.2006.00407.x","article-title":"Serial cardioversion by class IC Drugs during 4 months of persistent atrial fibrillation in the goat","volume":"17","author":"Eijsbouts","year":"2006","journal-title":"JCardiovasc Electrophysiol."},{"key":"2026020922045727200_jvim15242-bib-0032","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/0002-9149(86)90022-6","article-title":"Flecainide versus quinidine for conversion of atrial fibrillation to sinus rhythm","volume":"58","author":"Borgeat","year":"1986","journal-title":"Am J Cardiol."},{"key":"2026020922045727200_jvim15242-bib-0033","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1016\/j.ahj.2010.02.035","article-title":"A multicenter, open-label study of vernakalant for the conversion of atrial fibrillation to sinus rhythm","volume":"159","author":"Stiell","year":"2010","journal-title":"Am Heart J."},{"key":"2026020922045727200_jvim15242-bib-0034","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1177\/107424840100600403","article-title":"Efficacy of amiodarone for the termination of chronic atrial fibrillation and maintenance of normal sinus rhythm: a prospective, multicenter, randomized, controlled, double blind trial","volume":"6","author":"Galper\u00edn","year":"2001","journal-title":"JCardiovasc Pharmacol Ther."},{"key":"2026020922045727200_jvim15242-bib-0035","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1161\/01.CIR.94.7.1613","article-title":"Efficacy and safety of repeated intravenous doses of ibutilide for rapid conversion of atrial flutter or fibrillation. Ibutilide Repeat Dose Study Investigators","volume":"94","author":"Stambler","year":"1996","journal-title":"Circulation."},{"key":"2026020922045727200_jvim15242-bib-0036","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1002\/clc.4960211013","article-title":"Propafenone versus procainamide for conversion of atrial fibrillation to sinus rhythm","volume":"21","author":"Mattioli","year":"1998","journal-title":"Clin Cardiol."},{"key":"2026020922045727200_jvim15242-bib-0037","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1002\/(SICI)1099-081X(199711)18:8<649::AID-BDD51>3.0.CO;2-T","article-title":"Effects of pentobarbital on pharmacokinetics and pharmacodynamics of a potent fibrinogen receptor antagonist, L-734,217, in dogs","volume":"18","author":"Prueksaritanont","year":"1997","journal-title":"Biopharm Drug Dispos."},{"key":"2026020922045727200_jvim15242-bib-0038","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1097\/00000542-198609000-00005","article-title":"Effects of inhalational anesthetics on verapamil pharmacokinetics in dogs","volume":"65","author":"Chelly","year":"1986","journal-title":"Anesthesiology."},{"key":"2026020922045727200_jvim15242-bib-0039","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1097\/00005344-199102000-00004","article-title":"Influence of pentobarbital and chloralose anesthesia on quinidine-induced effects on atrial refractoriness and heart rate in the dog","volume":"17","author":"Boucher","year":"1991","journal-title":"JCardiovasc Pharmacol."},{"key":"2026020922045727200_jvim15242-bib-0040","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/S0022-3565(25)28896-6","article-title":"The pathophysiology of barium: hypokalemic and cardiovascular effects","volume":"177","author":"Roza","year":"1971","journal-title":"JPharmacol Exp Ther."},{"key":"2026020922045727200_jvim15242-bib-0041","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.ejphar.2015.11.026","article-title":"Pharmacological exploration of the resting membrane potential reserve: Impact on atrial fibrillation","volume":"771","author":"Van der Heyden","year":"2016","journal-title":"Eur J Pharmacol."}],"container-title":["Journal of Veterinary Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjvim.15242","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/jvim\/article-pdf\/32\/5\/1549\/66670174\/jvim15242.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jvim\/article-pdf\/32\/5\/1549\/66670174\/jvim15242.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T03:07:30Z","timestamp":1770692850000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jvim\/article\/32\/5\/1549\/8449609"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,1]]},"references-count":41,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,9,1]]}},"URL":"https:\/\/doi.org\/10.1111\/jvim.15242","relation":{},"ISSN":["1939-1676"],"issn-type":[{"value":"1939-1676","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,9]]},"published":{"date-parts":[[2018,9,1]]},"assertion":[{"value":"2018-01-23","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-05-21","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-08-05","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}